| Primary |
| Schizophrenia |
39.6% |
| Bipolar Disorder |
12.6% |
| Psychotic Disorder |
9.3% |
| Schizoaffective Disorder |
9.3% |
| Depression |
3.6% |
| Anxiety |
3.0% |
| Pain |
2.7% |
| Extrapyramidal Disorder |
2.5% |
| Hypertension |
2.5% |
| Affective Disorder |
1.9% |
| Hypothyroidism |
1.9% |
| Paranoia |
1.6% |
| Bipolar I Disorder |
1.4% |
| Dyspepsia |
1.4% |
| Insomnia |
1.4% |
| Musculoskeletal Pain |
1.4% |
| Dry Skin |
1.1% |
| Schizoaffective Disorder Bipolar Type |
1.1% |
| Constipation |
0.8% |
| Diabetes Mellitus |
0.8% |
|
| Weight Increased |
10.1% |
| Oedema Peripheral |
8.1% |
| Dizziness |
7.5% |
| Orthostatic Hypotension |
7.2% |
| Death |
5.9% |
| Tachycardia |
5.9% |
| Retrograde Ejaculation |
5.5% |
| Nausea |
4.9% |
| Vomiting |
4.9% |
| Hypotension |
4.2% |
| Priapism |
4.2% |
| Drug Ineffective |
3.9% |
| Dyspnoea |
3.6% |
| Palpitations |
3.6% |
| Psychotic Disorder |
3.6% |
| Pulmonary Embolism |
3.6% |
| Sedation |
3.6% |
| Headache |
3.3% |
| Insomnia |
3.3% |
| Somnolence |
3.3% |
|
| Secondary |
| Schizophrenia |
40.7% |
| Type 1 Diabetes Mellitus |
10.8% |
| Product Used For Unknown Indication |
8.7% |
| Depression |
8.2% |
| Hypertension |
7.8% |
| Blood Cholesterol Abnormal |
3.9% |
| Affective Disorder |
3.5% |
| Bipolar Disorder |
3.0% |
| Anxiety |
2.6% |
| Psychotic Disorder |
1.7% |
| Bladder Disorder |
1.3% |
| Abnormal Behaviour |
0.9% |
| Constipation |
0.9% |
| Dyslipidaemia |
0.9% |
| Extrapyramidal Disorder |
0.9% |
| Hypothyroidism |
0.9% |
| Osteopenia |
0.9% |
| Osteoporosis |
0.9% |
| Pain |
0.9% |
| Psychiatric Symptom |
0.9% |
|
| Arthralgia |
17.1% |
| Syncope |
9.8% |
| Weight Increased |
8.5% |
| Snoring |
7.3% |
| Vomiting |
7.3% |
| Pulmonary Embolism |
6.1% |
| Death |
4.9% |
| Schizophrenia |
4.9% |
| Concomitant Disease Progression |
3.7% |
| Pneumonia |
3.7% |
| Respiratory Failure |
3.7% |
| Tachycardia |
3.7% |
| Bladder Disorder |
2.4% |
| Drug Ineffective |
2.4% |
| Dyspnoea |
2.4% |
| Hypoaesthesia |
2.4% |
| Insomnia |
2.4% |
| Mastication Disorder |
2.4% |
| Swollen Tongue |
2.4% |
| Wrong Technique In Drug Usage Process |
2.4% |
|
| Concomitant |
| Schizophrenia |
20.5% |
| Product Used For Unknown Indication |
19.2% |
| Bipolar Disorder |
12.8% |
| Depression |
9.0% |
| Attention Deficit/hyperactivity Disorder |
5.1% |
| Psychotic Disorder |
5.1% |
| Hallucination |
3.8% |
| Autism |
2.6% |
| Blood Pressure Increased |
2.6% |
| Body Height Below Normal |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Head Circumference Abnormal |
2.6% |
| Sleep Disorder |
2.6% |
| Abnormal Behaviour |
1.3% |
| Anxiety |
1.3% |
| Bipolar I Disorder |
1.3% |
| Contraception |
1.3% |
| Dyslipidaemia |
1.3% |
| Insomnia |
1.3% |
| Rheumatoid Arthritis |
1.3% |
|
| Wrong Technique In Drug Usage Process |
12.0% |
| No Adverse Event |
8.0% |
| Therapeutic Response Decreased |
8.0% |
| Visual Impairment |
8.0% |
| Angioedema |
4.0% |
| Antipsychotic Drug Level Increased |
4.0% |
| Anxiety |
4.0% |
| Bipolar Disorder |
4.0% |
| Blood Pressure Increased |
4.0% |
| Blood Prolactin Increased |
4.0% |
| Chest Discomfort |
4.0% |
| Completed Suicide |
4.0% |
| Death |
4.0% |
| Gynaecomastia |
4.0% |
| Hallucination |
4.0% |
| Hyperhidrosis |
4.0% |
| Incorrect Dose Administered |
4.0% |
| Increased Appetite |
4.0% |
| Off Label Use |
4.0% |
| Poor Quality Drug Administered |
4.0% |
|
